Mirae Asset Global Etfs Holdings Ltd. Tarsus Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,143 shares of TARS stock, worth $997,542. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,143
Previous 20,926
5.82%
Holding current value
$997,542
Previous $1.16 Million
1.81%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.5MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$149 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$147 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$118 Million6.87% of portfolio
-
Jennison Associates LLC2.49MShares$112 Million0.09% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$111 Million8.19% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.2B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...